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ABSTRACT
Pancreatic endocrine progenitors obtained from human embryonic stem cells (hESCs) represent
a promising source to develop cell-based therapies for diabetes. Although endocrine pancreas pro-
genitor cells have been isolated from mouse pancreata on the basis of Ngn3 expression, human en-
docrine progenitors have not been isolated yet. As substantial differences exist between human
and murine pancreas biology, we investigated whether it is possible to isolate pancreatic endocrine
progenitors from differentiating hESC cultures by lineage tracing of NGN3. We targeted the 39 end
of NGN3 using zinc finger nuclease-mediated homologous recombination to allow selection of
NGN3eGFP+ cells without disrupting the coding sequence of the gene. Isolated NGN3eGFP+ cells ex-
press PDX1, NKX6.1, and chromogranin A and differentiate in vivo toward insulin, glucagon, and so-
matostatin single hormone-expressing cells but not to ductal or exocrine pancreatic cells or other
endodermal,mesodermal, or ectodermal lineages. This confirms thatNGN3+ cells represent pancreatic
endocrineprogenitors in humans. In addition, this hESC reporter line constitutes a unique tool thatmay
aid in gaining insight into the developmental mechanisms underlying fate choices in human pancreas
and in developing cell-based therapies. STEM CELLS TRANSLATIONALMEDICINE 2014;3:489–499
INTRODUCTION
Human embryonic stem cells (hESCs) are consid-
ered a promising source of b cells to treat diabe-
tes mellitus type 1. Growth factors and/or small
molecules have been used to generate insulin-
producing b cells from hESCs [1–5]. Evidence
exists that hESC-derived b cells, like primary
islets, can reverse hyperglycemia. For example,
several groups have grafted mixed embryonic
stem cell (hESC) progeny consisting chiefly of
PDX1- and NKX6.1-expressing cells to reverse hy-
perglycemia in diabetic mice. However, develop-
ment of normoglycemia required long-term in
vivo maturation of the hESC-derived pancreatic
endoderm [2, 3]. Kelly et al. selected pancreatic
endoderm progenitors with an anti-CD142 anti-
body or endocrine cells with an anti-CD200 and
-CD318 antibody. CD142-selected cells yielded
islet-like clusters, ductal tissue, and exocrine tis-
sue after implantation, whereas the CD200- and
CD318-enriched population gave rise mainly to
GCG+ cells [6]. All these studies relied on the
transplantation of mixed or not completely pure
end-stage cell populations, which in some cases
led to the generation of teratomas [2, 3]. There-
fore, understanding the developmental mecha-
nisms involved in human pancreas specification
and developing cell therapies from stem cells are
hampered by the heterogeneity of their differenti-
ated progenies. Although many studies have al-
ready been performed in mice, it appears that
developmental regulation is not always conserved
among species. The few studies performed in hu-
man tissue using immunohistological analyses [7,
8], gene expression profiling [9, 10], and transplan-
tation experiments of fetal pancreatic tissue of no
less than7weeksandupto23weeksofage [11,12]
support this idea. For example, the secondary
transition, a restricted period within mouse islet
development when b cells are generated, is not
apparent in human development but instead
occurs throughout the whole period of gesta-
tion. Thus, there is need for amoreprecise and re-
liable tool to address specific questions related to
human pancreatic development.
In addition, in terms of clinical applications, it
is unclear whether endocrine progenitors or ma-
ture b cells will be the best cell population for
b-cell replacement therapies. Currently, genera-
tion of mature b cells from pluripotent stem cells
(PSCs) in vitro remains challenging and still re-
quires complex in vivo signals to fully reach mat-
uration [13]. Endocrine pancreas progenitors can
be used to dissect the cues needed to generate
functional pancreatic islet cells.
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TISSUE-SPECIFIC PROGENITOR AND STEM CELLS
For these reasons,wehypothesized that the isolationof a spe-
cific pancreatic endocrine progenitor population would provide
a useful tool for the characterization ofmechanisms that underlie
generation of b cells from hESCs in vitro and/or in vivo and could
serve eventually as a valuable and safe source for cell therapy.
Ngn3-expressing cells are known to give rise to all hormone-
secreting endocrine cell types in the mouse pancreas [14]. Upon
maturation of islet cells, Ngn3 is no longer expressed [15]. There-
fore, NGN3 might be a useful marker for the identification of hu-
man pancreatic endocrine progenitors. In this study, we explored
this possibility by selecting NGN3-expressing cells from differen-
tiating hESCs in vitro. Zinc finger nuclease (ZFN)-mediated homol-
ogous recombination was used to target a selectable cassette at
the C terminus of NGN3, allowing the isolation, purification, and
characterization of NGN3-expressing cells. Pure NGN3eGFP+ cells
gave rise in vivo to single hormone-expressing endocrine cells,
confirming their pancreatic endocrine commitment for the first
time in humans.
MATERIALS AND METHODS
Cell Culture
hESC lines H9 and H1were purchased fromWiCell Research Insti-
tute (Madison, WI, http://www.wicell.org) and cultured accord-
ing to the manufacturer’s recommendations on feeder layers.
Experiments were performed at KU Leuven with approval from
theMedical Ethics Committee (UZ Leuven, Gasthuisberg). For dif-
ferentiation purposes, cells were harvested through enzymatic
dissociation and plated on 2% Matrigel-coated wells (Becton,
Dickinson and Company, Franklin Lakes, NJ, http://www.bd.
com) in mTESR medium (StemCell Technologies, Vancouver,
BC, Canada, http://www.stemcell.com). After the cells reached
60%–70% confluence, differentiation was initiated. Pancreatic
differentiation medium consisted of 55% Dulbecco’s modified
Eagle’s medium with 1,000 mg/l D-glucose, sodium pyruvate,
2% fetal bovine serum, 0.1% (0.1 mM) b-mercaptoethanol, 1%
penicillin-streptomycin liquid (Life Technologies, Rockville, MD,
http://www.lifetech.com), 40% MCDB 201 medium with trace
elements, L-glutamine, 30 mM HEPES, 1% ITS+1 (1003), and
1% (0.1 mM) L-ascorbic acid (all from Sigma-Aldrich, St. Louis,
MO, http://www.sigmaaldrich.com). Wnt3a (50 ng/ml) and
Activin A (100 ng/ml) were used for stage 1. Noggin (100 ng/ml)
and anti-Sonic hedgehog (SHH) (2.5 mg/ml) (both from R&D Sys-
tems Inc., Minneapolis, MN, http://www.rndsystems.com), nico-
tinamide (NA) (10 mM), and retinoic acid (RA) (10 mM) (both
from Sigma-Aldrich) were added from day 4 until day 16 (stage 2).
The NGN3eGFP+ enriched cells were cultured as clusters:
10,000 cells per well were plated in 96-well low-attachment
plates with noggin, anti-SHH, RA, and NA. To allow cluster forma-
tion, plateswere spunat200g for 5minutes.After 2days,medium
was replaced with RPMI 1640 medium (Life Technologies) with
0.05 wt% bovine serum albumin (BSA) containing NA (10 mM)
(Sigma-Aldrich) and insulin-like growth factor II (IGF-II) (50 ng/
ml) (R&D Systems) for an additional 24 days.
NGN3 Gene Targeting and Cell Sorting
A specific NGN3 ZFN set was generated to target the gene at the
C-terminal region of the protein (Sigma-Aldrich). The different
components for the NGN3 gene-targeting vector were cloned
in the pCR2.1 plasmid (Life Technologies; sequence shown in
supplemental online Table 4). Two to 3million hESCs were nucle-
ofected with 20 mg of gene targeting vector and 5 ml of ZFNs
mRNA using hESC Nucleofector Solution 2, program A13 (Lonza,
Walkersville, MD, http://www.lonza.com) following the manu-
facturer’s instructions. Cells were plated on inactivated DR4
mouse embryonic fibroblasts (GlobalStem, Rockville, MD, http://
globalstem.com) in media containing 10 mM ROCK inhibitor
(Sigma-Aldrich). Selection with hygromycin (Sigma-Aldrich; H9,
50mg/ml;H1,25mg/ml) forupto2weekswasperformed.Surviving
colonies were individually picked and expanded. Genotyping poly-
merase chain reactions (PCRs) were performed according to stan-
dard procedures.
Southern Blot
The Southern blots were performed using the DIG High Prime
DNA Labeling and Detection Starter Kit II (Roche, Indianapolis,
IN, http://www.roche.com) according to the manufacturer’s
instructions. The sets of primers used for the generation of the
probes can be found in supplemental online Table 2.
Teratoma Formation and Analysis
hESCs were collected through enzymatic dissociation, resus-
pended in 120ml of phosphate-buffered saline, and injected with
120ml ofMatrigel subcutaneously in theback of severe combined
immunodeficient RAG2gc-knockout mice. Tumors generally de-
velopedwithin 4–8weeks. Animals were sacrificed for dissection,
and teratomas were fixed in 4% paraformaldehyde (overnight)
and subsequently embedded in paraffin. After sectioning, the
presence of cells from three germ layers was assessed following
hematoxylin and eosin staining.
Array Comparative Genomic Hybridization
and Karyotyping
Genomic DNA was isolated from NGN3eGFP-H9 (three different
clones,n =2of eachclone) andwild-type (WT) hESCs (n= 2), all hav-
ing passage numbers between 40 and 57 using the QiaAmp DNA
mini kit (Qiagen, Hilden, Germany, http://www.qiagen.com), and
subjected to copy number variation analysis on 180k Cytosure ISCA
v2 arrays (Oxford Gene Technology, Oxford, U.K., http://www.ogt.
co.uk).One representative cloneof eachNGN3eGFP-hESCH9orH1
line and their WT counterparts were further analyzed by standard
cytogenetic proceduresatpassagenumbersof 50 forWTand60 for
transgenic cell lines.
Immunocytochemistry of NGN3eGFP+ Cells
Becauseof theautofluorescenceandmultilayerednatureof theday
16 differentiation hESC cultures, a thorough optimization of the
staining procedure for NGN3 and green fluorescent protein (GFP)
was needed. The human hepatocarcinoma cell line Huh7.5 (Amer-
ican Type Culture Collection, Manassas, VA, http://www.atcc.org),
transfected with an NGN3eGFP-Puromycin expression vector, was
used to optimize the NGN3 and GFP staining procedure. The
NGN3eGFP-Puromycin cassette, amplified by reverse transcription
(RT)-PCR using day 16 differentiated progeny as template, was
cloned into a vector containing the CAGGS constitutive promoter
and confirmed by sequencing. Huh7.5-transfected cells and day
16 progeny were fixed with 10% neutral buffered formalin, incu-
batedwith10%donkey serumblockingsolution,andpermeabilized
with 0.2% Triton X-100 (Sigma-Aldrich). Optimized staining
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conditions established by using the NGN3eGFP-Puromycin-
expressing Huh7.5 cells as control cells required an amplifica-
tion step for anti-NGN3 antibody (R&D Systems) using the Tyr-
amide Signal Amplification kit (PerkinElmer Life and Analytical
Sciences, Waltham, MA, http://www.perkinelmer.com). This
was not needed for the staining with the anti-GFP antibody
(Abcam, Cambridge, U.K., http://www.abcam.com).
Fluorescence-activated cell sorting (FACS)-selectedGFP+ cells
were stainedwith an anti-NGN3 antibody (R&D Systems)without
need of amplification. A list of all antibodies used on the
NGN3eGFP+ cells can be found in supplemental online Tables 3
and 4. DAPI was used as the nuclear counterstain in all cases.
Images of the day 16 differentiation hESC cultures were obtained
using the AxioImager-Z1, and images of the sorted cells were
obtained using the Nikon A1R Eclipse Ti.
FACS
Day 16 hESC differentiated progeny was sorted using the FACSAria
III cell sorter (BD Biosciences, San Diego, CA, http://www.
bdbiosciences.com).
RNA Isolation and Quantitative RT-PCR
Total RNAwas extracted using the RNeasymicrokit (Qiagen), and
cDNAwas synthesized from 1mg of total RNA using Superscript III
reverse transcriptase (Life Technologies). Quantitative RT-PCR
(qRT-PCR) was performed on a Mastercycler ep Realplex instru-
ment using specific primers (listed in supplemental online
Table 2) andPlatinumSyBRGreenqPCRSuperMix-UDG (Life Tech-
nologies). PPIA was used as a housekeeping control gene, and
results are shown in fold change using the 22DDCt method for rel-
ative quantification.
In Vitro C-Peptide Production
C-peptide releasewas challengedby incubating the further differ-
entiated NGN3eGFP+ clusters in Krebs-Ringer solution with bicar-
bonate and HEPES (KRBH; 129 mM NaCl, 4.8 mM KCl, 2.5 mM
CaCl2, 1.2 mM, KH2PO4, 1.2 mM MgSO4, 5 mM NaHCO3, 10
mM HEPES, 0.1% (wt/vol) BSA (all from Sigma-Aldrich). The clus-
ters were washed three times using KRBH. A 30-minute exposure
with KRBH was considered a non-stimulating condition; this me-
dium was kept for normalization purposes and was followed by
a 1-hour incubation with stimulation medium containing ei-
ther 2.5 mM D-glucose, 20 mM D-glucose, 2.5 mM D-glucose with
1 mM 3-isobutyl-1-methylxanthine (IBMX) and 30 mM KCl or
20 mM D-glucose with 50 mM nifedepine (all from Sigma-
Aldrich). Samples were analyzed for C-peptide release using the
ultra-sensitive C-peptide (Mercodia) and C-peptide ELISA kit
(Mercodia).
Transplantation Under the Kidney Capsule
NGN3eGFP+ cells were transplanted under the kidney capsule of
RAG2gc-knock-out mice.
Immunohistochemistry and Fluorescence In
Situ Hybridization
Kidney grafts were fixed with 4% paraformaldehyde, embedded
in paraffin and stained according to standard procedures using
10% of donkey serum blocking solution and 0.2% Triton X-100
(Sigma-Aldrich) permeabilization solution. Staining of the grafts
with anti-GFP (Clontech, Mountain View, CA, http://www.
clontech.com) required amplification of the signal using the
Tyramide Signal Amplification kit (PerkinElmer). This kit was used
according tomanufacturer’s instructionswith fluorescein isothio-
cyanate fluorophores. A list of all antibodies can be found in
supplemental online Tables 3 and 4.
After immunofluorescence staining, grafts were further pro-
cessed for fluorescence in situ hybridization (FISH). The human
CotI DNA probe (Life Technologies) was labeled using the Bio-
prime Total Genomic labeling system (Life Technologies), diluted
in hybridization buffer (6.15 g of dextran sulfate, 20 ml of form-
amide, 4 ml of 203 standard saline citrate (SSC), and 18 ml of
water, brought to pH 7 with HCl [all from Sigma-Aldrich]) and
denatured at 85°C for 4 minutes. Hybridization of the slides were
performed at 37°C O/N. Thereafter, the slides were washed for 2
minutes in 0.43 SSC (Life Technologies) with 0.3% Igepal-CA630
(Sigma-Aldrich), 1 minute in 23 SSC with 0.1% Igepal-CA630, and
5 minutes in 23 SSC. For chromogranin A (CHGA) staining, FISH
was performed first, followed by immunostaining. DAPI was used
as nuclear counterstain in all the cases. Images of the sections
were taken using the AxioImager-Z1 (Carl Zeiss, Jena, Germany,
http://www.zeiss.com).
Statistical Analyses
Data values obtained on the differentiation were subject to the
two-tailed Student’s t test. Values of p , .05 (p), p , .01 (pp),
and p , .001 (ppp) were considered statistically significant.
RESULTS
Generation of NGN3eGFP-hESC Lines
ZFNs were generated recognizing unique sites adjacent to the
stop codon of theNGN3 gene. A gene targeting vector containing
two isogenic homology regions of up to 800 bp each that flanked
the targeting locus was created. Upon correct targeting, the
NGN3 translation stop codon was deleted and the protein was
tagged with a polycistronic cassette containing the enhanced
green fluorescent protein (eGFP) and puromycin resistance cas-
sette (PuroR) linked by T2A and P2A sequences (Fig. 1A), which
led to the production of three individual proteins once NGN3
was expressed. An EF1a-hygromycinR/thymidine kinase (Hyg/
TK) fusion cassette allowed the selection of recombinant clones.
After nucleofection of the ZFNs and the targeting vector in
H9- and H1-hESCs, antibiotic selection was performed and 18
and 5 hygromycin-resistant colonies, respectively, weremanually
picked. Of these, 12 of 18 H9 colonies and 4 of 5 H1 colonies were
correctly targeted without random integrations (supplemental
online Fig. 1), and the genotypes of three clones of each linewere
further characterized by Southern blot (Fig. 1B). Genome editing
basedonhomologous recombinationwith ZFNs is known to cause
off-target mutations, which could affect ESC characteristics.
Therefore, the genetically modified cell lines were assessed for
maintenance of pluripotency and genome integrity. The targeted
lines expressed the pluripotency markers OCT4, NANOG, SOX2,
TRA-1-60, and SSEA4 (Fig. 1C) and formed teratomas wherein
cells of the three germ layers could bedetected (Fig. 1D).Genome
integrity was assessed by both array comparative genomic hy-
bridization (aCGH), due to thehigher sensitivity fordetecting copy
number variations than traditional cytogenetic techniques, and
conventional karyotyping. aCGH demonstrated that no genetic
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abnormalities were present after ZFN treatment and that the kar-
yotype and ploidy of both NGN3eGFP-hESC lines were normal
(supplemental online Table 1; supplemental online Fig. 2).
Differentiation of hESCs Toward Endocrine Pancreas
We used the protocol depicted in Fig. 2A to differentiate hESCs
toward endocrine pancreas. Activin A and Wnt3a were used for
induction of definitive endoderm [1, 16, 17]. We next used
amix of anti-SHH antibody, to inhibit SHH signaling [18], RA to di-
rect ESCs toward endocrine pancreas by inducing PDX1 expres-
sion [19], noggin to inhibit BMP signaling [17, 19], and NA,
which is known to induce differentiation and maturation of
undifferentiated fetal pancreatic cells [20].Weevaluated thediffer-
entiation process using WT H9 cells by qRT-PCR on days 0, 4, 10,
12, 14, and 16. Transcript levels for the pluripotency genes OCT4
and NANOG decreased from day 4 onward and were no longer
expressed following day 10. Transcripts of the primitive streak
marker genes (EOMES and MIXL1) were maximally expressed on
day 4, and transcripts for the definitive endoderm genes (CXCR4,
FOXA2 and SOX17) increased from day 4 to days 10–12 but de-
creasedafterward (supplemental onlineFig. 3). Fromday4onward,
we could detect transcripts for the pancreatic endocrine gene
PDX1, followed by an increase inNGN3, NEUROD1, andNKX6.1 ex-
pression levels. INS andGCG transcript levels increasedmoderately
and SSTwasnotexpressedas comparedwithundifferentiated cells,
Figure 1. Characterization of theNGN3eGFPhumanembryonic stemcell (hESC) lines. (A): Schematic overviewof thewild-type allele, targeting
vector and targeted NGN3 alleles. Red lines: probes used in Southern blot; white boxes: coding sequences; black lines: Zinc finger nuclease
genomic recognition site; dark gray boxes: 39 untranslated region; light gray boxes: T2A and P2A sequences; eGFP and PURO-pA: PuromycinR
gene and polyadenylation signal; white arrows, EF1a promoter; Hyg/TK, hygromycinR-thymidine kinase fusion gene. Polymerase chain reaction
genotyping primers are indicated in blue (amplification of the integration) and red (amplification of random integrants). (B): Southern blot of
NGN3eGFP-hESC lines. Genomic DNAwas digested with AvrII and hybridized with external (59) and internal (39) probes. (C): Immunostaining of
theNGN3eGFP-hESC lines for pluripotencymarkersOCT4, NANOG, SOX2, SSEA4, andTRA-1-60. Scale bars = 100mm. (D):Hematoxylin andeosin
stainingof teratomasections generated fromtheNGN3eGFP-hESC lines representing all three lineages. Scalebars =25mm.Abbreviations: EF1a,
human elongation factor 1a; huEF1a, human elongation factor 1a; wt, wild-type.
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which did not express any of these pancreatic genes (Fig. 2B), but
expression levels remained ∼9,000-, ∼2,000-, and ∼80,000-fold
lower, respectively, than in human pancreas (data not shown).
The transgenic cell lines were further assessed for their in vitro
differentiation potential by directing them toward endocrine
pancreatic-like cells as described above. No significant differences
in the transcript levels of these genes were observed betweenWT-
H9andNGN3eGFP-H9ofday16progeny,whereas somepancreatic
genes in NGN3eGFP-H1 differentiated progeny expressed levels
lower comparedwithWT-H1cells (supplemental online Fig. 4a). This
observation may be explained either by the experimental variation
commonly seen during hESC differentiation or by a moderate loss
ofdifferentiationpotentialof thetransgenic linesafter thegeneedit-
ing process. In any case, estimation of the relevance of this finding
is difficult, as direct comparison of in vitro differentiation potential
to the specific lineage studiedaftergene targetinghasnotpreviously
been assessed in hESC lineage tracing studies [21–28]. When this
protocol was used to differentiate theWT-H1 line, gene expression
of pancreatic endocrine genes was also different from WT-H9 on
day 16 (supplemental online Fig. 4b), reflecting the common obser-
vation that different human ESC lines have different abilities to dif-
ferentiate to specific lineages [1, 17, 19, 29].
As robust NGN3 expression could be detected between day
12 and day 16, we choose day 12 for the initiation of the
puromycin selection and day 16 to isolate committed NGN3+ cells
from the targeted lines. In order to determine the faithfulness of
the knockin add-on, we analyzed GFP and NGN3 expression on
nonselected day 16progeny ofNGN3eGFP-H9 and -H1 expressing
cells. The specificity of both antibodieswas first testedonpositive
controlHuh7.5 cells (Fig. 3D; supplemental online Fig. 5d) toeven-
tually demonstrate that the GFP signal colocalizes consistently
with the NGN3 expression in the transgenic lines (Fig. 3A–3C;
supplemental online Fig. 5a–5c). Some studies have suggested
that retention of the cassette used for the selection of recombi-
nant clonesmay interferewith the faithfulness of the lineage spe-
cific reporter cassette [24, 30]. However, in day 16 progeny of
NGN3eGFP-H1 and -H9 cell lines, all GFP+ cells were NGN3+ and
all NGN3+ cells were GFP+, demonstrating that the reporter lines
faithfully express GFP from the endogenous NGN3 locus and rul-
ing out the need to remove the selectable cassette.
The differentiating hESCs were treated with 600 ng/ml puro-
mycin from day 12 to day 16 to pre-enrich the NGN3eGFP+ frac-
tion (ranging from 0.3% to 2%) before FACS (Fig. 4A). To ensure
rapid selection of highly purified cells, two sequential sorts were
performed (Fig. 4B): first, a low purity stringency sort that recov-
ered all putative positive cells and pre-enriched the NGN3+ cell
population up to 25%, followed by a high purity stringency sort.
The final purity of the FACS-selected NGN3eGFP+ cells was
Figure 2. Generation of NGN3eGFP+ cells from the NGN3eGFP-hESC lines. (A): The differentiation scheme depicts the mix of factors used to
commit hESCs toward endocrine pancreas. (B): Transcript levels for different pancreatic genes during endocrine pancreas differentiation using
H9 cells. All results shown are from three ormore independent experiments. Data are represented asmean6 SEM. Asterisks indicate statistical
significance asdeterminedby t test. Valuesofp, .05 (p),p, .01 (pp), andp, .001 (ppp)were considered statistically significant. Abbreviations:
D, day; hESC, human embryonic stem cell; NA, nicotinamide; RA, retinoic acid; SHH, Sonic hedgehog.
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90.9% 6 2.5% (n = 3); the remaining ∼10% can be mostly
accounted for by cell debris, as determined by their low forward
scatter and side scatter (Fig. 4B). The NGN3eGFP+ cells expressed
NGN3 mRNA at levels 63-fold higher than unsorted cells (sup-
plemental online Fig. 6a).
Characterization of the NGN3eGFP+ Cells From
Differentiating hESCs
To characterize the FACS-purifiedNGN3eGFP+ cells, we used qRT-
PCR and immunostaining. Aside from the 63-fold increased tran-
script levels ofNGN3, other pancreaticmarker genes (PDX1,NEU-
ROD1, PAX4, ARX, PAX6, NKX2.2, NKX6.1, INS, SST, and GCG)
were significantly enriched compared with the unsorted fraction
(Fig. 5A). Although we could detect INS, SST, and GCG tran-
scripts in NGN3eGFP+ progenitors, immunostaining demon-
strated that protein expression was very faint (supplemental
online Fig. 6b). A similar mRNA expression profile has been de-
scribed by Xu et al. for the most committed subpopulation of
Ngn3-expressing cells (eGFP+-high side scatter [eGFP/HSSC]) iso-
lated from adult mouse pancreas after partial duct ligation [31].
Likemouse eGFP-HSSCs, humanNGN3eGFP+ cells did not express
SOX9 or PTF1a transcripts. PTF1a is not required for NGN3 spec-
ification [32], whereas SOX9 is expressed in early multipotential
progenitors of the pancreas during development [33], indicating
that the human NGN3eGFP+ cells may already have passed
through that stage. HLXB9 and HNF6 transcripts were present
in NGN3eGFP+ cells but at levels similar to those in the unsorted
population (Fig. 5A), likely because of the upstream and more
widespread expression of these genes [34]. All eGFP+ cells stained
positive for NGN3 (confirming again the faithfulness of the
knockin), PDX1, and NKX6.1, further confirming their progenitor
state. In addition, NGN3eGFP+ cells stained positive for CHGA
(Fig. 5B) but were negative for CD142 (data not shown). CHGA
was recently shown to be absent in pancreatic endodermal pro-
genitors but present on endocrine cells derived from hESCs [6].
NGN3eGFP+ Cells Undergo Further Maturation In Vitro
To induce further differentiation of theNGN3eGFP+ cells to pancre-
atic endocrine hormone-producing cells, we plated NGN3eGFP+
cells in low-attachment plates to allow cell cluster formation.
The clusters were maintained for an additional 24 days with IGF-
II and NA, a combination of factors previously shown to support
invitromaturationofprogenitors to INS+cells [35].Transcript levels
for NGN3 were, as expected with maturation, significantly down
regulated, whereas expression levels ofNKX6.1 and the endocrine
hormones INS, GCG, and SSTwere significantly increased (Fig. 5C).
We assessed the glucose responsiveness of the NGN3eGFP+-
derived clusters. Exposure to 20 mM D-glucose did not induce se-
cretion of C-peptide. However, stimulation with KCl and the phos-
phodiesterase inhibitor IBMX induced C-peptide release. On the
other hand, nifedipine, a calcium antagonist, blocked the basal
C-peptide release seen with 20 mM glucose-stimulation (Fig.
5D). These findings are in accordancewith other published reports
and may reflect the significantly lower levels of INS expression in
the in vitro NGN3eGFP+ clusters compared with islets of Langer-
hans [1, 35, 36].
NGN3eGFP+ Cells Have the Capacity to Differentiate
Toward Endocrine Hormone-Expressing Cells In Vivo
Approximately 200,000 NGN3eGFP+ cells were transplanted im-
mediately after sorting under the kidney capsuleof normoglycemic
immunodeficient mice to assess whether further maturation
occurs in vivo.Micewere sacrificed after 8–9weeks, and kidneys
were harvested. Grafts were present in all transplanted mice,
Figure 3. NGN3 and GFP immunocytochemistry of NGN3eGFP-hESCs-derived day 16 progeny. Day 16 NGN3eGFP-hESCs-derived cells (un-
sorted and nonselected) (A, B), undifferentiated hESCs (C), and NGN3-GFP transfected Huh7.5 cells (D)were stainedwith anti-NGN3 to confirm
the colocalization of NGN3 and GFP. Scale bars = 100mm. Abbreviations: DAPI, 49,6-diamidino-2-phenylindole; GFP, green fluorescent protein;
hESC, human embryonic stem cell.
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Figure 4. Isolation ofNGN3eGFP+ cells from theNGN3eGFPhumanembryonic stemcell (hESC) lines. (A):Bright field, eGFP, and overlay images
of puromycin-selected differentiation cultures. Scale bar = 100mm. (B): Fluorescence-activated cell sorting plots showing the sorting strategy to
enrich forNGN3eGFP+ cells. TheNGN3eGFP+ cellswere first sorted in yieldmodeby gating on theGFP+ cells, followed by purity sort according to
both their forward and side scatter profiles and GFP signal. After the purity sort, cells were reanalyzed to check for purity. Abbreviations: BF,
bright field; BFeGFP, overlay of bright field and eGFP; d, day; FITC, fluorescein isothiocyanate; FSC, forward scatter; SSC, side scatter.
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and human cells could be identified by FISHwith a specific human
DNACotI probe (supplemental online Fig. 7). Human cells positive
for CHGAweredetected (Fig. 6A), aswell as INS,GCG, andSST (Fig.
6B–6D). Some of the CHGA+ cells stained positive for INS, GCG, or
SST (Fig.6C,6D,6F,6G).Althoughsomeauthorshavenoticed INS+/
GCG+ and INS+/SST+ cells in hESC-derived grafts [1, 3], no double
hormone positive cells were found in our grafts. Likewise, no
NGN3eGFP+ cells were detected (Fig. 6E). Immunostaining for
exocrine marker Amylase and the ductal marker CK19 was nega-
tive. As NGN3-expressing cells can also give rise to glial precursor
cells [37],we testedwhether theNGN3eGFP+-derived cells stained
positive for GFAP, but we did not find positive cells. The grafted
cellswerealsonegative for the livermarkerAlbumin; the intestinal
markers CDX2, MUCIN-2, and LYSOZYME; the neuronal marker
b-tubulin III; and the mesodermal marker a-smooth muscle actin
(data not shown). Teratomas were not detected.
Figure 5. Characterization of isolatedNGN3eGFP+ cells and in vitromaturation in response to insulin-like growth factor II (IGF-II) andNA. (A, B):
Freshly isolated NGN3eGFP+ cells: fold change of pancreatic markers compared with unsorted cell population (A) and immunostaining for GFP,
PDX1, NGN3, NKX6.1, and CHGA (B). Scale bars = 25 mm (top two rows), 50 mm (middle two rows), and 25 mm (bottom two rows). (C): Sorted
NGN3eGFP+ cells cultured for 24 days with IGF-II and NA. Shown are relative mRNA expression levels of pancreatic markers compared with the
initial NGN3eGFP sorted fraction. (D): C-peptide release of NGN3eGFP+-derived clusters was induced with 2.5 mM, 20 mM glucose, 2.5 mM D-
glucose with 1 mM IBMX, and 30 mM KCl or 20 mM D-glucose with 50 mM nifedepine. All results shown are from three or more independent
experiments. Data are represented as mean 6 SEM. Asterisks indicate statistical significance as determined by t test. Values of p , .05 (p),
p, .01 (pp), and p, .001 (ppp) were considered statistically significant. Abbreviations: DAPI, 49,6-diamidino-2-phenylindole; GFP, green fluo-
rescent protein; hESC, human embryonic stem cell; IBMX, 3-isobutyl-1-methylxanthine; ND, not detected; NE, nonexpressed.
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DISCUSSION
Manyattemptshavebeenmadetogeneratepancreaticb cells from
pluripotent stem cells. An important hurdle that investigators gen-
erally face is the fact that most of these directed differentiations
generate mixed progeny, and therefore, the identification of the
specific cell population that contributes to the generation ofb cells
is unclear [1–3]. Here we used ZFN-mediated homologous recom-
bination to knock in an eGFP-PuroR cassette in the NGN3 gene in
hESCs. Most gene targeting studies in hESCs have disrupted one
copy of the gene of interest by introducing a selection cassette in
the initial coding exons [24, 26]. Abrogation of the expression of
one allele may cause haploinsufficiency of the gene of interest,
which may be important for key transcription factors, as has been
shown for Oct4 [38]. To retain bothNGN3 alleles intact, we choose
to insert a polycistronic 2A-linked reporter-selectable cassette at
the C terminus of NGN3, deleting the stop codon. This allowed
the selection of pure NGN3+ cells from mixed hESC progeny. To
our knowledge, this is the first detailed study reporting a knockin
add-on in a nonexpressed gene in hESCs, which allows for the suc-
cessful isolation of a specific cell lineage.
We selected NGN3eGFP+ cells from hESC progeny instructed to
differentiate to endodermwith Activin A andWnt3, followed by dif-
ferentiation toward endocrine pancreas. The NGN3eGFP+-sorted
cells could be further differentiated in vitro to endocrine cells when
culturedwithpresenceof IGF-II andNA, althoughnoglucose respon-
siveness couldbedetected. This isnotunexpected, asexpression lev-
els for INS, GCG, and SST remained 10- to 100-fold lower than in
human islets. We also further demonstrated that pure NGN3eGFP+
cells,when transplanted immediately after sortingunder the kidney
capsule of immunodeficient mice, generated CHGA+ progeny that
costainedmainly single-positive for INS, GCG, or SST, whereas nei-
ther ductal nor exocrine pancreatic cells were identified. The fact
that we could identify relatively few cells under the kidney capsule
may be attributable to the low number of transplanted cells [2, 3,
39] or the need for amore appropriate environment for further dif-
ferentiation,whichmight be providedby cotransplantationof pan-
creatic embryonic tissue [6]. Under the current differentiation
protocol, the number of NGN3eGFP+ cells was low, precluding
transplantation of more cells. However, the availability of the
NGN3eGFP-hESC reporter line should now enable the develop-
ment of improved differentiation protocols.
Lineage tracingstudies inmousedemonstratedthatNgn3+cells
from both embryonic and adult pancreas tissue are endocrine pro-
genitors that give rise to all endocrine cells and suggested that re-
generationmayrecapitulatedevelopmentalpathways [40].Xuetal.
alsodemonstratedthatNgn3eGFP+cells isolated fromregenerating
pancreas in the adult mouse contain eGFP+ low side scatter (eGFP/
LSSC) cells that are similar to NGN3eGFP+ cells from embryonic
day 13.5, further supporting the previous study [31]. Aside from
the eGFP/LSSC population, another Ngn3+ subpopulation (eGFP/
HSSC), more granulated and believed to be more committed,
was also detected and showed an expression profile comparable
to that of the human ESC-derivedNGN3eGFP+ cells described here.
Using differentiating hESCs, Kelly et al. demonstrated that CD142+/
PDX1+/NKX6.1+/CHGA2 cells give rise to all three pancreatic cell
types and representpancreatic endoderm [6].On thebasis of these
murine and human studies, we believe that the NGN3eGFP+ cells
isolated in the current study, which are also PDX1+ and NKX6.1+,
do not express CD142 or PTF1A but express CHGA, mature in vivo
to islet cells, and are pancreatic endocrine progenitors. Thus, our
findings provide new insight in the development of pancreatic en-
docrine fate specification in human.
The NGN3eGFP-hESC lines will be a useful tool for optimiza-
tion of hESC differentiation protocols, as they will allow high-
throughput screening for small molecules, which can help in-
crease the number of NGN3eGFP+ cells during differentiation
[4, 5], as well as for molecules that may stimulate NGN3+ cell dif-
ferentiation toward b cells. In addition, the purified NGN3eGFP+
cell fraction should allowthe identificationof cell-surfacemarkers
Figure 6. NGN3eGFP+ cells transplanted under the kidney capsule give rise to endocrine-positive progeny. (A–E): Fluorescence in situ hybrid-
ization with labeled CotI DNA and/or immunostaining for CHGA, INS, GCG, SST, and GFP. Human CHGA+ cells are indicated by green arrows (A).
(B): Human INS+ and GCG+ cells (green and purple arrows, respectively). Single-positive INS (green arrows), GCG (purple arrows), and SST (ma-
genta arrows) cells coexpressed CHGA (C, D). NGN3eGFP+ cells were not detected in the graft (E). (F, G): Magnification of CotI, CHGA, and
SST (E) and CotI, CHGA, and INS (F). Scale bars = 50 mm (A–C, E), 100 mm (D), and 20 mm (F, G). Abbreviations: CHGA, chromogranin A; DAPI,
49,6-diamidino-2-phenylindole.
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that could then be used to detect NGN3+ cells in fetal and post-
natal tissues [31, 40]. Finally, it will be of interest to test whether
the NGN3eGFP-hESC line could be used to isolate glial, intestine,
or gut progenitors fromhESC cultures directed toward the neuro-
ectodermal or intestinal lineage.
CONCLUSION
We demonstrated that NGN3eGFP+ cells prospectively isolated
from differentiating hESCs can develop further toward single-
hormone expressing cells in vivo, providing proof of principle
for the purification of a human pancreatic endocrine progenitor.
We also demonstrated that the NGN3eGFP knockin add-on strat-
egy is a reliable and powerful tool for lineage tracing purposes
that can also be used in other areas of human stem cell research.
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